Genitourinary Cancer
Research
The Development of an eHealth Tool Suite for Prostate Cancer Patients and Their Partners
News
Intermittent Androgen Suppression 'Noninferior' to Continuous in Prostate Cancer
Major Finding: Median overall survival associated with intermittent androgen suppression therapy for rising PSA level after radiotherapy was 8.8...
Audio
Community Oncology Podcast - Abiraterone in metastatic prostate cancer
News
FDA Approves Enzalutamide for Prostate Cancer
Commentary
Will They Still Give Strong to Lance Armstrong's Cancer Charity?
Video
ASCO 2012: Radium-223 and Prostate Cancer Survival
News
Blood Test May Predict Temsirolimus Response in Kidney Cancer
Major Finding: Median overall survival among patients who had high lactate dehydrogenase at baseline was significantly longer in those who were...
News
New Analysis Revises Benefits of PSA Screening Downward
Major Finding: Screening 1,000 men aged 55-69 years would save 9 men from prostate cancer with a gain of 73 unadjusted life-years but only 56...
Conference Coverage
Experimental Drug Improves Muscle Strength in Cancer
Major Finding: The experimental drug enobosarm significantly improved physical function on a stair-climb test by 17% in hypogonadal men with...